WEISMAN HOWARD J. (Chief Executive Officer) sold 1.2% of their position (8.05K shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/30/2023ACC: 0001062993-23-019819
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-8.05K
Net shares
Net seller
$1.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.05K
Price / share
$0.19
Trade value
$1.52K
% of position
1.2%
10/27/2023
657.60K→649.55K
Total
Net shares
−8.05K
Net value
-$1.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2023 | S · Sale | −8.05K | $0.19 | $1.52K | 1.2% | 657.60K | 649.55K |
| Total | −8.05K | -$1.52K | ||||||
Derivative Transactions0
No derivative transactions reported